Newsroom
Congress presence ·

VSY Biotechnology and Alsanza to Exhibit Together at ESCRS 2026

Both Evmann Group companies will present their ophthalmology portfolios at the 44th Congress of the ESCRS, running from 11 to 15 September at ExCeL London.

The waterfront promenade at ExCeL London, congress banners along the venue facade.

VSY Biotechnology and Alsanza, the two ophthalmology and orthopedics companies of the Evmann Group, will exhibit jointly at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). The congress takes place at ExCeL London from 11 to 15 September 2026 and remains the largest annual gathering of cataract and refractive surgeons in Europe.

The two companies will share a 75 square metre stand, open on two sides, where surgeons and distributors can review current intraocular lens (IOL), toric lens and viscoelastic device platforms in person.

What each company is presenting

VSY Biotechnology will present its intraocular lens portfolio, including the Enova range spanning presbyopia and cataract indications. Among the platforms on display is Enova Advanced, VSY's non-diffractive extended depth-of-focus (EDOF) lens, which is the subject of a newly published Phase 4 clinical study covered separately in this Newsroom.

Alsanza will present its ophthalmology and orthopedics ranges, including its toric IOL portfolio for astigmatism correction and its ophthalmic viscosurgical devices (OVD), used to protect ocular tissue during cataract and refractive procedures.

A shared standard

Both companies operate under the Evmann Group tagline, "Inspiring Life Through Science", reflecting a shared commitment to CE and MDR-compliant, evidence-led device development across the group's ophthalmology, orthopedics and medical aesthetics businesses.

Surgeons, distributors and press attending ESCRS 2026 are welcome to visit the VSY Biotechnology and Alsanza stand for product demonstrations and clinical data throughout the congress.

Sources

44th Congress of the ESCRS, ExCeL London, 11 to 15 September 2026 (congress.escrs.org; excel.london).

Companies: VSY Biotechnology · Alsanza

Media contact: Evmann Press Office

About Evmann

Evmann is a European medical technology group operating through VSY Biotechnology, Alsanza and Alsanza Aesthetics across three clinical fields: ophthalmology, orthopedics and medical aesthetics. The group unites integrated research, development and manufacturing, rigorous regulatory discipline and long-term partnerships with healthcare professionals behind every company in the group. Headquartered in the Netherlands, Evmann delivers science-driven solutions to healthcare professionals in 40+ countries. Inspiring Life Through Science.

For media

Media Kit

Approved logos of Evmann, VSY Biotechnology, Alsanza and Alsanza Aesthetics; the group boilerplate; leadership portraits; a one-page group fact sheet. Available on request, versioned and dated.

Request

Press contact

General and media inquiries reach the group directly.

Contact us